ArticleTherapeutic advances in gastroenterology2025

Comparative efficacy and safety of vonoprazan versus esomeprazole-based high-dose dual therapies for first-line

Wei-Chen Tai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.